A

Active Director Designated Partner DIN 11967353
DIN 11967353 First appointment Sep 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Asya

Asya is a Designated Partner at Heins Pharma Llp (since 2026).

DIN 11967353
Primary Designation Designated Partner
First Appointment 24 Sep 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Heins Pharma Llp ADC-6603
Designated Partner24 Sep 20262026Active

Board colleagues of Asya

NameDINCompanyDesignation
Sulaikha11967354Heins Pharma LlpDesignated Partner
Abhinav Krishnalekha SureshkumarHeins Pharma LlpPartner
Bahiya Haris Rachana11967352Heins Pharma LlpDesignated Partner
Moidu Kannoth11967351Heins Pharma LlpDesignated Partner
Muhammad Sajir KeezhattilHeins Pharma LlpPartner

Directorship timeline

Open interactive timeline →
Heins Pharma Llp
Premium access

Shareholding and investment profile for Asya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Asya

Asya currently holds 1 directorship: Heins Pharma Llp (Designated Partner, since 24 Sep 2026).

Asya was first appointed on 24 Sep 2026 as Designated Partner at Heins Pharma Llp.

The current boards of Asya's companies include Sulaikha (Heins Pharma Llp), Abhinav Krishnalekha Sureshkumar (Heins Pharma Llp), Bahiya Haris Rachana (Heins Pharma Llp), Moidu Kannoth (Heins Pharma Llp), Muhammad Sajir Keezhattil (Heins Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available